Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude launching Angstrom II and Contour II ICDs by March 1.

This article was originally published in The Gray Sheet

Executive Summary

ST. JUDE MEDICAL's ANGSTROM II, CONTOUR II ICD MARKET LAUNCH is anticipated by March 1, the firm reports Feb. 9. The products were approved by FDA Feb. 2 via premarket approval application supplements. The Angstrom II, with a volume of 44 cc, is the smallest implantable cardioverter defibrillator on the market, while the 57 cc Contour II is the most powerful, with up to 42 joules of maximum stored energy.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel